NCT02770794View on ClinicalTrials.gov

Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

211

Participants

Timeline

Start Date

April 1, 2016

Primary Completion Date

August 14, 2020

Study Completion Date

August 14, 2020

Conditions
Arthritis, Rheumatoid
Interventions
DRUG

Infliximab

Discontinue infliximab; receive Infliximab when relapse

Trial Locations (1)

260-8677

Chiba University Hospital, Chiba

All Listed Sponsors
lead

Chiba University

OTHER

NCT02770794 - Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter